Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Angiotensin-converting enzyme inhibitors in the management of congestive heart failure: a pharmaceutical industry perspective.

Authors :: Boccuzzi SJ
Source :: American heart journal [Am Heart J] 1999 May; Vol. 137 (5), pp. S120-2.
Publication Year :: 1999

Subjects :: Drug Industry trends
Economics, Pharmaceutical
Evidence-Based Medicine
Heart Failure economics
Humans
Practice Guidelines as Topic
Treatment Outcome
United States
Angiotensin-Converting Enzyme Inhibitors economics
Angiotensin-Converting Enzyme Inhibitors therapeutic use
Drug Industry economics
Health Care Costs
Heart Failure drug therapy

Full Text Access

Tools